Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003649
What this trial is testing

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Not applicableNot Yet RecruitingNCT07287904
What this trial is testing

Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data

Who this might be right for
Lung Cancer (NSCLC)EGFR Activating MutationAdenocarcinoma Lung+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00958321
What this trial is testing

Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

Who this might be right for
Lung CancerMetastatic Cancer
Cancer Trials Ireland 40
Testing effectiveness (Phase 2)Study completedNCT03184571
What this trial is testing

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer MetastaticNSCLC Stage IVAdenocarcinoma of Lung
BerGenBio ASA 99
Testing effectiveness (Phase 2)Active Not RecruitingNCT04533451
What this trial is testing

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung AdenocarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Adenocarcinoma+4 more
Alliance for Clinical Trials in Oncology 101
Early research (Phase 1)Active Not RecruitingNCT05783622
What this trial is testing

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more
Janux Therapeutics 130
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Not applicableStudy completedNCT00004138
What this trial is testing

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 303
Not applicableUnknownNCT02946216
What this trial is testing

ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer MetastaticAdenocarcinoma of Lung+1 more
First People's Hospital of Hangzhou 200
Early research (Phase 1)Study completedNCT05867121
What this trial is testing

Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma
Genentech, Inc. 102
Testing effectiveness (Phase 2)UnknownNCT00178698
What this trial is testing

Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors

Who this might be right for
Neuroendocrine CancerSmall Cell Lung CancerNon-Small Cell Lung Cancer+1 more
The University of Texas Health Science Center, Houston 36
Early research (Phase 1)Looking for participantsNCT05983432
What this trial is testing

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Who this might be right for
Non Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more
SystImmune Inc. 540
Testing effectiveness (Phase 2)Active Not RecruitingNCT03110978
What this trial is testing

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Atypical Carcinoid TumorLung Neuroendocrine NeoplasmLung Non-Small Cell Squamous Carcinoma+11 more
M.D. Anderson Cancer Center 140
Testing effectiveness (Phase 2)Study completedNCT02664935
What this trial is testing

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerCarcinoma, Squamous CellAdenocarcinoma
University of Birmingham 423
Early research (Phase 1)Study completedNCT03502330
What this trial is testing

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Who this might be right for
Advanced MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Yale University 42
Testing effectiveness (Phase 2)Study completedNCT00950365
What this trial is testing

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Bronchioloalveolar CarcinomaLarge Cell Lung CarcinomaLung Adenocarcinoma+3 more
Albert Einstein College of Medicine 79
Early research (Phase 1)Study completedNCT00753415
What this trial is testing

V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Who this might be right for
Non-Small Cell Lung CarcinomaBreast CancerMelanoma+5 more
Merck Sharp & Dohme LLC 37
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Testing effectiveness (Phase 2)Looking for participantsNCT05902988
What this trial is testing

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung Cancer+7 more
Volastra Therapeutics, Inc. 200
Next Page